Contributors: Universitair Ziekenhuis Brussel = University Hospital of Brussels (UZ Brussel); Photomécanique et analyse expérimentale en mécanique des solides Institut Pprime (PEM); Département Génie Mécanique et Systèmes Complexes Institut Pprime (Département GMSC); Institut Pprime UPR 3346 (PPrime Poitiers ); Université de Poitiers = University of Poitiers (UP)-École Nationale Supérieure de Mécanique et d’Aérotechnique Poitiers (ISAE-ENSMA )-Centre National de la Recherche Scientifique (CNRS)-Université de Poitiers = University of Poitiers (UP)-École Nationale Supérieure de Mécanique et d’Aérotechnique Poitiers (ISAE-ENSMA )-Centre National de la Recherche Scientifique (CNRS)-Institut Pprime UPR 3346 (PPrime Poitiers ); Université de Poitiers = University of Poitiers (UP)-École Nationale Supérieure de Mécanique et d’Aérotechnique Poitiers (ISAE-ENSMA )-Centre National de la Recherche Scientifique (CNRS)-Université de Poitiers = University of Poitiers (UP)-École Nationale Supérieure de Mécanique et d’Aérotechnique Poitiers (ISAE-ENSMA )-Centre National de la Recherche Scientifique (CNRS); Philippe Rigoard reports grants and personal fees from Medtronic, Abbott, and Boston Scientific, outside the submittedwork. Rui V Duarte has received consultancy fees from Medtronic, Boston Scientific, Mainstay Medical, and SaludaMedical. Sam Eldabe has received consultancy fees from Medtronic, Mainstay Medical, Boston Scientific, and Abbott.His department received research funding from the National Institute of Health Research, Medtronic, and Nevro. LisaGoudman is a postdoctoral research fellow funded by the Research Foundation Flanders (FWO), Belgium (project12ZF622N). Maarten Moens has received speaker fees from Medtronic and Nevro. STIMULUS received independentresearch grants from Medtronic. The authors report no other conflicts of interest in this work.
نبذة مختصرة : International audience ; Despite the well-known efficacy of spinal cord stimulation (SCS) in chronic pain management, patient selection in clinicalpractice remains challenging. The aim of this review is to provide an overview of the factors that can influence the process of patientselection for SCS treatment. A sequential decision-making model is presented within a tier system that operates in clinical practice.The first level incorporates the underlying disease as a primary indication for SCS, country-related reimbursement rules, and SCSscreening–trial criteria in combination with underlying psychological factors as initial selection criteria in evaluating patient eligibilityfor SCS. The second tier is aligned with the individualized approach within precision pain medicine, whereby individual goals andexpectations and the potential need for preoperative optimizations are emphasized. Additionally, this tier relies on results fromprediction models to provide an estimate of the efficacy of SCS in the long term. In the third tier, selection bias, MRI compatibility,and ethical beliefs are included, together with recent technological innovations, superiority of specific stimulation paradigms, and newfeedback systems that could indirectly influence the decision-making of the physician. Both patients and physicians should be aware ofthe different aspects that influence patient selection in relation to SCS for pain management to make an independent decision onwhether or not to initiate a treatment trajectory with SCS
Processing Request
No Comments.